Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-9 of 9 for your search:
Cancer Type/Condition:
clear cell sarcoma of the kidney
Stage/Subtype:
clear cell sarcoma of the kidney
Country:
U.S.A.
Trial Type:
Treatment
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase I/II Study of Dasatinib in Combination With Ifosfamide, Carboplatin, and Etoposide Phosphate in Young Patients With Metastatic or Recurrent Malignant Solid Tumors
Phase:
Phase II, Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
1 to 25
Sponsor:
NCI, Pharmaceutical / Industry
Protocol IDs:
CHNMC-07053
, 07053, CA180 121, NCT00788125
2.
Phase II Study of Combination Chemotherapy, Radiotherapy, and/or Surgery in Patients With High-Risk Renal Tumors
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
Under 30
Sponsor:
NCI
Protocol IDs:
COG-AREN0321
, AREN0321, NCT00335556
3.
Phase 2 Study in Patients With MiT Tumors
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
13 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
ARQ 197-204
, NCT00557609
4.
Phase II Study of Therapeutic Angiotensin-(1-7) as Second- or Third-Line Treatment in Patients With Metastatic or Unresectable Sarcoma
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
CCCWFU-71108
, CCCWFU 71108, IRB00008212, NCT00974545
5.
Phase I Study of Interleukin-12 and Interleukin-2 in Patients With Refractory or Advanced Solid Tumors
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
NCI-00-C-0121
, NCI-41, 41, NCT00020163
6.
Proton Beam Radiation Therapy in Treating Patients With Retroperitoneal Sarcoma
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
UPCC 04509
, NCT01034566
7.
Comparison of Immune Response Following Surgical Management of Renal Tumors
Phase:
No phase specified
Type:
Natural history/Epidemiology, Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
IRB3 021-2005
, NCT00289146
8.
Respiratory Tumor and Normal Tissue Motion
Phase:
No phase specified
Type:
Natural history/Epidemiology, Treatment
Status:
Active
Age:
Not specified
Sponsor:
Other
Protocol IDs:
2003-0962
, NCT00415675
9.
Comparison of Standard of Care or Treatment on Protocol
Phase:
No phase specified
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
INST 0813
, NCT01010334
Select All on Page
Help with Results
